01556nam0 22003493i 450 VAN0029277220250513013735.447N978303087324020250513d2021 |0itac50 baengCH|||| |||||i e bcrSARS-CoV-2 Spike Protein Convergent EvolutionImpact of Virus Variants on Efficacy of COVID-19 Therapeutics and VaccinesDaniele FocosiChamSpringer2021XIII, 136 p.ill.24 cm001VAN002835292001 SpringerBriefs in Microbiology210 ChamSpringer2011-CHChamVANL001889616.079Immunologia22579.2Virologia. Virus e organismi subvirali22FocosiDanieleVANV2456671072599Springer <editore>VANV108073650ITSOL20250516RICAhttps://link.springer.com/book/10.1007/978-3-030-87324-0E-book - Accesso al full-text attraverso riconoscimento IP di Ateneo, proxy e/o ShibbolethBIBLIOTECA DEL DIPARTIMENTO DI SCIENZE E TECNOLOGIE AMBIENTALI BIOLOGICHE E FARMACEUTICHEIT-CE0101VAN17NVAN00292772BIBLIOTECA DEL DIPARTIMENTO DI SCIENZE E TECNOLOGIE AMBIENTALI BIOLOGICHE E FARMACEUTICHE17CONS e-book 189 17BIB189/562 562 20250513 SARS-CoV-2 Spike Protein Convergent Evolution2568871UNICAMPANIA